Insider · CIK 0001678195

Lapidus Stanley

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001678195

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-20	LUCDLucid Diagnostics Inc.A Award	Director	AAward	+123K sh	—	—	337,392
2025-02-20	LUCDLucid Diagnostics Inc.A Award	Director	AAward	+113K sh	—	—	214,392
2024-02-22	LUCDLucid Diagnostics Inc. · Employee stock option (right to buy)A Award	Director	AAward	+150K sh	—	—	150,000
2023-09-26	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−9,747 sh	$1.45	−$14.1K	101,592
2023-09-26	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−10K sh	$1.43	−$14.3K	111,339
2023-09-26	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−10K sh	$1.47	−$14.7K	121,339
2023-09-25	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−200 sh	$1.43	−$286	131,339
2023-09-21	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−100 sh	$1.44	−$144	131,539
2023-09-21	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−100 sh	$1.44	−$144	131,539
2023-09-20	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−3,405 sh	$1.45	−$4,937.25	132,051
2023-09-20	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−3,405 sh	$1.45	−$4,937.25	132,051
2023-09-20	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−412 sh	$1.44	−$593.28	131,639
2023-09-20	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−412 sh	$1.44	−$593.28	131,639
2023-01-31	LUCDLucid Diagnostics Inc. · Employee stock option (right to buy)A Award	Director	AAward	+175K sh	—	—	175,000
2022-09-20	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−16.9K sh	$1.70	−$28.7K	135,456
2022-09-20	LUCDLucid Diagnostics Inc.S Sale	Director	SSale	−17K sh	$1.71	−$29K	152,320
2022-02-18	LUCDLucid Diagnostics Inc. · Employee stock option (right to buy)A Award	Director	AAward	+59K sh	—	—	59,000
2019-06-11	T2 Biosystems, Inc.S Sale	Director	SSale	−9,000 sh	$1.44	−$13K	53,010
2019-06-08	T2 Biosystems, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	—	—	62,010
2019-06-08	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	—	—	9,000
2019-06-07	T2 Biosystems, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2018-11-06	T2 Biosystems, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−27.1K sh	—	—	0
2018-11-06	T2 Biosystems, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+27.1K sh	$1.16	+$31.4K	59,058
2018-11-06	T2 Biosystems, Inc.S Sale	Director	SSale	−6,048 sh	$5.29	−$32K	53,010
2018-06-08	T2 Biosystems, Inc.Restricted Stock UnitsA Award	Director	AAward	+9,000 sh	—	—	9,000
2018-06-05	T2 Biosystems, Inc.S Sale	Director	SSale	−6,000 sh	$8.87	−$53.2K	32,000
2018-06-02	T2 Biosystems, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18K sh	—	—	38,000
2017-06-06	T2 Biosystems, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.16	+$23.2K	20,000
2017-06-06	T2 Biosystems, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	27,058
2017-06-02	T2 Biosystems, Inc.Restricted Stock UnitsA Award	Director	AAward	+18K sh	—	—	18,000
2017-06-02	T2 Biosystems, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+18K sh	—	—	18,000
2016-06-17	T2 Biosystems, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,647

Recent filings

Accepted (ET)
Feb 244
Lapidus Stanley0001094891-26-000070
SEC(opens sec.gov)
Feb 214
Lapidus Stanley0001062993-25-003193
SEC(opens sec.gov)
Feb 234
Lapidus Stanley0001062993-24-004285
SEC(opens sec.gov)
Sep 274/A
Lapidus Stanley0001062993-23-018551
SEC(opens sec.gov)
Sep 274
Lapidus Stanley0001062993-23-018552
SEC(opens sec.gov)
Sep 224
Lapidus Stanley0001062993-23-018421
SEC(opens sec.gov)
Feb 24
Lapidus Stanley0001062993-23-002038
SEC(opens sec.gov)
Sep 224
Lapidus Stanley0001062993-22-019850
SEC(opens sec.gov)
Feb 234
Lapidus Stanley0001062993-22-005490
SEC(opens sec.gov)
Jun 134
Lapidus Stanley0000899243-19-016822
SEC(opens sec.gov)
Jun 114
Lapidus Stanley0000899243-19-016463
SEC(opens sec.gov)

Companies

Address

360 MADISON AVENUE, 25TH FLOOR

NEW YORK, NY, 10017